
Arrange your collection
Choose your location, add the test to your care bag and select a time. If you are booking for someone else, assign the test to them in checkout.
Choose collection locationTumour Markers · Individual laboratory test
CEA is mainly used to follow certain established cancers, especially colorectal cancer. It is interpreted as a trend within the treating clinician's plan.
Clinical authorDr Nirupama SabhapathySpecialist Clinical Pathology
Understanding the test
Also called Colorectal Cancer Marker
CEA may provide a baseline that the oncology team can follow during treatment or surveillance, most commonly in an established colorectal cancer pathway.
CEA is sometimes measured during follow-up of established colorectal and other cancers.
Smoking, liver conditions and previous measurements can influence the clinical context.
Before your sample
No fast is needed. Tell the team if you smoke and bring the previous CEA values and collection dates when monitoring cancer treatment.
A clinician takes a small sample of blood from a vein. The laboratory uses serum, the liquid separated from the blood after it clots.
Smart Report
24 hoursLaboratory turnaround
Trends are interpreted alongside imaging and other clinical evidence. Smoking and some non-cancerous conditions can influence the level.
From sample to follow-up

Choose your location, add the test to your care bag and select a time. If you are booking for someone else, assign the test to them in checkout.
Choose collection locationLook for Carcino Embryonic Antigen (CEA) in your report. Use the sample type and collection time when comparing it with an earlier report.
Explore Smart Report
Keep track of the dates of cancer treatment, any smoking change and the laboratory used when reviewing a CEA trend.
Health packages
Compare the other tests in each package before choosing.
Patient questions
No. Some cancers do not raise CEA, and non-cancerous factors can raise it. It cannot replace appropriate screening or investigation of symptoms.
CEA is best known in colorectal cancer, where it tends to be higher when the disease is widespread rather than confined. Cancers of the pancreas, stomach, lung, breast, thyroid and ovary can also raise it. Many tumours release little or none, so CEA is used to follow a cancer already diagnosed rather than to find one.
Results from different assay platforms are not interchangeable, so a change between two laboratories may reflect the method rather than your disease. Keeping the same laboratory and, where practical, a similar time of day makes the trend reliable. Bring previous CEA reports so the readings can be plotted together.
KEEP EXPLORING
Open a package to see exactly which tests it includes.

A defined selection of tumour markers, with a blood count and stool occult blood, for clinician-directed assessment. These results cannot confirm or rule out cancer on their own.

A defined tumour-marker selection including PSA, with a blood count and stool occult blood, for clinician-directed assessment. Results cannot confirm or rule out cancer alone.

Blood count, liver, kidney, cholesterol, blood sugar and urine tests: the essentials in one visit.

A complete blood count with liver enzymes, cholesterol, kidney markers and fasting blood sugar from one blood sample.
Choosing for a particular need?
We can help you read the options.
Your next step
Written by Dr Nirupama Sabhapathy, Specialist Clinical Pathology. Medically reviewed by Dr Joyce Jose, Specialist Clinical Pathology, on .
Catalogue information and AED price checked on 2 November 2026. Clinical suitability, preparation, collection arrangements and turnaround are confirmed for your selected test.